Skip to main content
Print Save

969 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base))

Pill with imprint 969 is Orange, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base). It is supplied by Sun Pharmaceutical Industries Inc.

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 2 mg (base) / 0.5 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for 969

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 2 mg (base) / 0.5 mg (base) 969

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint
969
Strength
2 mg (base) / 0.5 mg (base)
Color
Orange
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC)
62756-0969
Inactive Ingredients
lactose monohydrate, mannitol, povidone, citric acid anhydrous, sodium citrate, FD&C Yellow No. 6, butylated hydroxyanisole, magnesium stearate, acesulfame potassium, corn starch

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "969"

Pill 93 896 Beige Round is Famotidine
Famotidine
Pill b 969 100 Brown Elliptical/Oval is Fluvoxamine Maleate
Fluvoxamine Maleate
Pill Z2969 Orange Capsule-shape is Sulfinpyrazone
Sulfinpyrazone

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer